| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | $1098.13 | -1.2% | $1.04T | 47.8 | 129% | 0.5% | Healthcare | 39.9% | 47.4% | ||
| 2 | Johnson & Johnson | $228.39 | -2.5% | $550.4B | 39.4 | 78.9% | 2.1% | Healthcare | 51.5% | 3.7% | ||
| 3 | AbbVie Inc. | $216.63 | -2.1% | $383.17B | 91.4 | -1.4% | 3% | Healthcare | 16.8% | 8.6% | ||
| 4 | Merck & Co., Inc. | $113.87 | -1.4% | $281.25B | 15.6 | 8.2% | 2.9% | Healthcare | 43.6% | 1.2% | ||
| 5 | Novartis AG | $147.08 | -2.5% | $280.64B | 20.5 | 9.2% | 2.7% | Healthcare | 26.8% | 5.3% | ||
| 6 | AstraZeneca PLC | $174.93 | -1.7% | $271.19B | 26.7 | 33.1% | 1.9% | Healthcare | 21.8% | 9.9% | ||
| 7 | Novo Nordisk A/S | $43.19 | -0.8% | $191.93B | 12.2 | 16.8% | 4.1% | Healthcare | -41.6% | 8.1% | ||
| 8 | Amgen Inc. | $337.60 | -1.2% | $182.2B | 23.7 | 31.1% | 2.8% | Healthcare | 16.6% | 9.1% | ||
| 9 | Gilead Sciences, Inc. | $123.76 | -1.3% | $153.66B | 18.3 | 54.5% | 2.6% | Healthcare | 14.6% | 3.5% | ||
| 10 | Pfizer Inc. | $25.22 | -2.7% | $143.46B | 18.5 | -5.1% | 6.8% | Healthcare | 5.6% | 1.4% | ||
| 11 | Bristol-Myers Squibb Company | $54.00 | -2.3% | $110.25B | 15.7 | 33.6% | 4.6% | Healthcare | 15.3% | 1.8% | ||
| 12 | Sanofi | $42.38 | -0.3% | $102.35B | 18.2 | 96.2% | 5.1% | Healthcare | -11% | 14.1% | ||
| 13 | GSK plc | $50.67 | -2.8% | $101.9B | 6.9 | 120.3% | 6.3% | Healthcare | 31.1% | 5.4% | ||
| 14 | Biogen Inc. | $196.58 | -1.1% | $29.02B | 22.3 | -7.8% | — | Healthcare | 55.4% | 0.4% | ||
| 15 | Grifols, S.A. | $7.40 | -0.8% | $6.26B | 11.3 | 114.9% | 2.8% | Healthcare | -14.9% | 1% | ||
| 16 | Organon & Co. | $13.43 | 0.1% | $3.53B | 18.7 | -67.7% | 2.5% | Healthcare | 35.9% | -2.1% | ||
| 17 | Bristol-Myers Squibb Company Ce | $0.11 | -1.4% | $225M | 0.0 | 33.6% | 100% | Healthcare | 289.4% | 1.8% | ||
| 18 | Scilex Holding Company | $7.47 | 5.2% | $63M | -0.2 | -148.5% | — | Healthcare | 55.9% | -33.2% | ||
| 19 | Citius Oncology, Inc. | $0.67 | 1.4% | $62M | -2.0 | -26.5% | — | Healthcare | -56.8% | — | ||
| 20 | MIRA Pharmaceuticals, Inc. | $0.95 | -2.6% | $40M | -0.7 | -177% | — | Healthcare | -22.6% | — | ||
| 21 | SRx Health Solutions Inc. | $0.12 | -38.3% | $4M | -0.1 | -252.3% | — | Healthcare | -79.3% | -127.5% |